Trial Profile
Use of OCs Containing Dienogest and Risk of Venous Thromboembolism.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2010
Price :
$35
*
At a glance
- Drugs Dienogest (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 04 Dec 2009 Actual number of patients changed from 681 to 3400 as reported by ClinicalTrials.gov.
- 05 Feb 2009 Actual number of patients added (681) as reported by ClinicalTrials.gov.
- 05 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.